Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BNT112 |
Trade Name | |
Synonyms | BNT 112|BNT-112|W_pro1 |
Drug Descriptions |
BNT112 is an mRNA-based cancer vaccine that encodes prostate cancer antigens, which may activates anti-tumor immune response (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178636 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BNT112 | BNT112 | 0 | 1 |
BNT112 + Cemiplimab | BNT112 Cemiplimab | 0 | 1 |